Validation of NFBD1 as a novel molecular target in cervical cancer therapy utilising advanced molecular approaches
Cervical cancer is the second most frequent cancer and the most common cause of death in women in developing countries, with HPV-16/18 infection being one of its major characteristics. Other than vaccination, chemotherapy is the most commonly used mode of treatment. However, recurrence of cancer aft...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Science Planet Inc.
2017-10-01
|
| Series: | Canadian Journal of Biotechnology |
| Online Access: | https://www.canadianjbiotech.com/CAN_J_BIOTECH/Archives/v1/Special Issue/cjb.2017-a164.pdf |